We are live on ! Find out more
TCA

Transcend Capital Advisors Portfolio holdings

AUM $1.25B
1-Year Est. Return 17.69%
This Fund
S&P 500
This Quarter Est. Return
+8.2%
1 Year Est. Return
+17.69%
3 Year Est. Return
+61.21%
5 Year Est. Return
+70.44%
10 Year Est. Return
AUM
$920M
AUM Growth
+$16.5M
Cap. Flow
-$29M
Cap. Flow %
-3.15%
Top 10 Hldgs %
25.72%
Holding
531
New
49
Increased
171
Reduced
238
Closed
40

Sector Composition

Rank Sector Weight
1 Financials 17.28%
2 Technology 15.78%
3 Healthcare 10.8%
4 Consumer Discretionary 4.5%
5 Communication Services 3.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLV
476
Clough Global Dividend & Income Fund
GLV
$78.1M
$102K 0.01%
15,987
+48
+0.3% +$329
SWN
477
DELISTED
Southwestern Energy Company
SWN
$92.9K 0.01%
15,881
+1,200
+8% +$7.89K
FLNT
478
Fluent
FLNT
$102M
$88.6K 0.01%
13,541
+666
+5% +$4.89K
DNA icon
479
Ginkgo Bioworks
DNA
$528M
$73.6K 0.01%
1,089
MITT
480
TPG Mortgage Investment Trust
MITT
$222M
$68K 0.01%
12,800
-5,200
-29% -$26.8K
OPK icon
481
Opko Health
OPK
$985M
$63.6K 0.01%
50,850
+20,000
+65% +$31.5K
SOFI icon
482
SoFi Technologies
SOFI
$21B
$53.6K 0.01%
11,619
-3,706
-24% -$18.4K
FIP icon
483
FTAI Infrastructure
FIP
$441M
$44.2K ﹤0.01%
+14,993
New +$41.5K
ORGO icon
484
Organogenesis Holdings
ORGO
$305M
$32.3K ﹤0.01%
+12,000
New +$35K
BBBY
485
DELISTED
Bed Bath & Beyond Inc
BBBY
$25.6K ﹤0.01%
10,200
ELVT
486
DELISTED
Elevate Credit, Inc.
ELVT
$17.5K ﹤0.01%
10,000
APTO
487
DELISTED
Aptose Biosciences, Inc.
APTO
$13.9K ﹤0.01%
53
CELG.RT
488
Bristol-Myers Squibb Rights
CELG.RT
$191M
$13.9K ﹤0.01%
117,775
OTLK icon
489
Outlook Therapeutics
OTLK
$183M
$10.8K ﹤0.01%
500
SFT
490
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
$5.3K ﹤0.01%
+3,562
New +$13.5K
CFRX
491
DELISTED
ContraFect Corporation
CFRX
$2.13K ﹤0.01%
278
ABR icon
492
CALL
Arbor Realty Trust
ABR
$964M
-25,000
Closed -$288K
BBY icon
493
Best Buy
BBY
$18.2B
-5,465
Closed -$346K
BDJ icon
494
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.73B
-10,403
Closed -$84K
BGB
495
Blackstone Strategic Credit 2027 Term Fund
BGB
$499M
-21,200
Closed -$225K
CARZ icon
496
First Trust Exchange-Traded Fund II First Trust S-Network Future Vehicles & Technology ETF
CARZ
$46M
-5,490
Closed -$223K
COIN icon
497
Coinbase
COIN
$38.6B
-6,324
Closed -$408K
CRWD icon
498
CrowdStrike
CRWD
$194B
-10,344
Closed -$426K
CTSH icon
499
Cognizant
CTSH
$24.9B
-4,797
Closed -$276K
CWI icon
500
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.78B
-31,300
Closed -$664K

Similar funds

Transcend Capital Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, Transcend Capital Advisors held 531 positions worth $920M, up 1.8% from $904M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Transcend Capital Advisors withdrew a net $29M in Q4 2022, closing 40 positions and reducing 238 holdings. Its most notable exit was KraneShares CSI China Internet ETF, an estimated $2.6M position sold in full.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Transcend Capital Advisors opened a new position in Putnam Focused Large Cap Value ETF worth $1.6M.

  • Transcend Capital Advisors's largest Q4 2022 buy was Putnam Focused Large Cap Value ETF: 59,240 shares worth $1.6M.
  • Transcend Capital Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2022, an estimated $9.5M increase.
  • Transcend Capital Advisors's biggest Q4 2022 reduction was Blue Owl Capital, cutting an estimated $8.87M.
  • Transcend Capital Advisors fully exited KraneShares CSI China Internet ETF in Q4 2022, selling an estimated $2.6M.
  • Transcend Capital Advisors's ten largest holdings make up 26% of its $920M portfolio in Q4 2022.
  • Transcend Capital Advisors opened 49 new positions and closed 40 in Q4 2022.
  • Transcend Capital Advisors's portfolio value rose 1.8% quarter-over-quarter to $920M.

Based on Transcend Capital Advisors's 13F filing for Q4 2022, filed 20 Jan 2023.